Instrument Inactif

Autres langues Nichi-Iko Pharmaceutical Co., Ltd.

Actions

4541

JP3687200000

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nakakita Yakuhin Co., ltd. acquired Yakuhan Pharmaceutical Co., Ltd. from Nichi-Iko Pharmaceutical Co., Ltd.	01/08/23
Nichi-Iko Pharmaceutical Co., Ltd.(TSE:4541) dropped from S&P Global BMI Index	20/03/23
Japan Shares End Flat on Last Trading Day of 2022; Nichi-Iko Pharmaceutical Shares Plummet 24%	30/12/22
Nichi-Iko Pharmaceutical Secures 98.5 Billion Yen of Debt Relief, Plans 20 Billion Yen Share Allotment; Shares Plunge 20%	30/12/22
Nichi-Iko Pharmaceutical More Than Triples Fiscal H1 Profit	12/12/22
Nichi-Iko Pharmaceutical Co., Ltd. announced that it expects to receive Ã‘19.998404811 billion in funding from Godo Kaisha JSD	14/11/22
Japan Index Trades Steadily in Red; Round One Shares Gain 9% as May Sales Exceed Pre-Pandemic Level	10/06/22
Chugai Appeals Tokyo Court's Dismissal of Patent Infringement Lawsuit Against Sawai, Nichi-iko Pharmaceutical	10/06/22
Court Denies Chugai's Claim in Lawsuit Against Sawai, Nichi-iko	30/05/22
Nichi-Iko Pharmaceutical's Nine-Month Profit Soars	10/03/22
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022（IFRS）	09/03/22
Nichi-Iko Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	09/03/22
Court Denies Chugai's Claim in Lawsuit Against Sawai, Nichi-iko and Nissan Chemical	25/02/22
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)	03/12/21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2022	03/12/21
Nichi Iko Pharmaceutical : 〔Delayed〕Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)	06/09/21
Nichi-Iko Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2021	06/09/21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Second Quarter and Full Year of Fiscal Ending March 31, 2022	06/09/21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2022	06/09/21
Nichi-Iko Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2022	06/09/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nichi-Iko Pharmaceutical Co., Ltd.

Actions

4541

JP3687200000

Autres langues

Filtres